Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
filingDate |
1990-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8928b08c1215397fbe931cc4897611a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8807f462d17e90914d5c7fb6a6cba15 |
publicationDate |
1991-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9104728-A2 |
titleOfInvention |
Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome |
abstract |
The use of agonists or antagonists of Mullerian Inhibiting Substance to suppress or treat respiratory distress syndrome. The treatment can be accomplished by providing an effective amount of the agonist or antagonist to a neonatal or prenatal individual. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0545772-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2684301-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5455226-A |
priorityDate |
1989-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |